Procollagen propeptide and pyridinium cross-links as markers of type I collagen turnover: Sex- and age-related changes in healthy children

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2971-2977

  Zanze, M ^a   Souberbielle, J C ^b   Kindermans, C ^b   Rossignol, C ^c   Garabedian, M ^a,d  

^a CNRS   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Ctr bilans sante l'enf CPAM Paris   (France)

^d HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PROCOLLAGEN; PROTEIN PRECURSOR; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

AGE; ARTICLE; BODY SIZE; COLLAGEN METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; NORMAL HUMAN; OSTEOLYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; SEX DIFFERENCE;

AGING; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; INFANT; MALE; PEPTIDES; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 0030929048     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.2971     Document Type: Article

References (29)

1. Calvo MS, Eyre DR, Gundberg CM. 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 17:333-368.
2. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CGD, Mowat AP. 1991 Serum concentrations of type 1 and 3 procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res. 30:276-280.
3. Saggese G, Bertelloni S, Baroncelli GI, Di Nero G. 1992 Serum levels of carboxyterminal propeptide of type 1 procollagen in healthy chilren from 1st year of life to adulthood and in metabolic bone diseases. Eur J Pediatr. 151:764-768.
4. Kubo T, Tanaka H, Inoue M, Kanzaki S, Seino Y. 1995 Serum levels of carboxyterminal propeptide of type 1 procollagen and pyridinoline crosslinked telopeptide of type 1 collagen in normal children and children with growth hormone (GH) deficiency during GH therapy. Bone. 17:397-401.
5. Blumsohn A, Naylor KE, Assiri AMA, Eastell R. 1995 Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem. 41:1592-1598.
6. Eyre DR. 1984 Cross-linking in collagen and elastin. Annu Rev Biochem. 53:717-748.
7. Rauch F, Schönau E, Woitge H, Remer T, Seibel M. 1994 Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children. Exp Clin Endocrinol. 102:94-97.
8. Fujimoto S, Kubo T, Tanaka H, Miura M, Seino Y. 1995 Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab. 80:1922-1928.
9. Branca F, Robins SP, Ferro-Luzzi A, Golden MHN. 1992 Bone turnover in malnourished children. Lancet. 340:1493-1496.
10. Eyre DR, Ericsson L, Simon L, Krane S. 1988 Identification of urinary peptides derived from cross-linking sites in bone collagen in Paget's disease. J Bone Miner Res. 3(Suppl 1):S210.
11. Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantification of type 1 collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
12. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. 1994 Immunoassay for quantifying type 1 collagen degradation products in urine evaluated. Clin Chem. 40:2022-2025.
13. Bollen AM, Eyre DR. 1994 Bone resorption rates in children monitored by the urinary assay of collagen type 1 cross-linked peptides. Bone. 15:31-34.
14. Haycock GB, Chir B, Schwartz GJ, Wisotsky DH. 1978 Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Pediatr. 93:62-66.
15. Melkko J, Niemi S, Risteli L, Risteli J. 1990 Radioimmunoassay of the carboxyterminal propeptide of human type 1 procollagen. Clin Chem. 36:1328-1332.
16. Kamel S, Brazier M. 1992 High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption. J Chromatogr. 574:255-260.
17. Eyre DR. 1987 Collagen cross-linking amino-acids. In: Cunningham LW, ed. Methods in enzymology. New York: Academic Press; 115-139.
18. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. 1994 Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res. 9:1643-1649.
19. Lieuw-A-Fa M, Sierra RI, Specker BL. 1995 Carboxy-terminal propeptide of human type 1 collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age. J Bone Miner Res. 10:849-853.
20. Beadsworth LJ, Eyre DR, Dickson IR. 1990 Changes with age in the urinary excretion of lysyl-and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res. 5:671-676.
21. Tsukahara H, Miura M, Hori C, et al. 1996 Urinary excretion of pyridinium cross-links of collagen in infancy. Metabolism. 45:510-514.
22. Açil Y, Brinckmann J, Notbohm H, Müller PK, Bätge B. 1996 Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). Scand J Clin Lab Invest. 56:275-283.
23. Robins SP. 1994 Biochemical markers for assessing skeletal growth. Eur J Clin Nutr. 48(Suppl 1):S199-S209.
24. Kamel S, Brazier M, Neri V, et al. 1995 Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immumoassay methods. J Bone Miner Res. 10:1385-1392.
25. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. 1995 Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res. 10:641-649.
26. Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C. 1996 High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone. 19:291-298.
27. Blumsohn A, Hannon RA, Wrate R, et al. 1994 Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol (Oxf). 40:663-670.
28. Robins SP. 1995 Collagen crosslinks in metabolic bone disease. Acta Orthop Scand. 66(Suppl 266):171-175.
29. Shaw NJ, Dutton J, Fraser WD, Smith CS. 1995 Urinary pyridinoline and deoxypyridinoline excretion in children. Clin Endocrinol (Oxf). 42:607-612.